Access cutting-edge ibs-c treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access ibs-c specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ibs-c treatment provided free
This is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C when administered twice daily (BID) for 12 consecutive weeks.
Sponsor: Ardelyx
Check if you qualify for this ibs-c clinical trial in Orlando, FL
If you're searching for ibs-c treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ibs-c specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.